UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

Impact of Stopping Trastuzumab in Early Breast Cancer: A Population-Based Study in Ontario, Canada

JNCI : Journal of the National Cancer Institute, 2020-12, Vol.112 (12), p.1222-1230

2020

Volltextzugriff (PDF)

Results of the phase I CCTG IND.231 trial of CX-5461 in patients with advanced solid tumors enriched for DNA-repair deficiencies

Nature communications, 2022-06, Vol.13 (1), p.3607-3607, Article 3607

2022

Volltextzugriff (PDF)

Young Women with Breast Cancer: The Current Role of Precision Oncology

Journal of personalized medicine, 2023-11, Vol.13 (11), p.1620

2023

Volltextzugriff (PDF)

Reproductive Outcomes in Young Breast Cancer Survivors Treated (15-39) in Ontario, Canada

Current oncology (Toronto), 2022-11, Vol.29 (11), p.8591-8599

2022

Volltextzugriff (PDF)

Capturing the True Cost of Breast Cancer Treatment: Molecular Subtype and Stage-Specific per-Case Activity-Based Costing

Current oncology (Toronto), 2023-08, Vol.30 (9), p.7860-7873

2023

Volltextzugriff (PDF)

Cardiac Monitoring and Heart Failure in Advanced Breast Cancer Patients Treated With Trastuzumab in Ontario, Canada

Frontiers in cardiovascular medicine, 2022-05, Vol.9, p.850674-850674

2022

Volltextzugriff (PDF)

Pursuing Connectivity in Cardio-Oncology Care—The Future of Telemedicine and Artificial Intelligence in Providing Equity and Access to Rural Communities

Frontiers in cardiovascular medicine, 2022-06, Vol.9, p.927769-927769

2022

Volltextzugriff (PDF)

Arsenic Metalation of Seaweed Fucus vesiculosus Metallothionein: The Importance of the Interdomain Linker in Metallothionein

Biochemistry (Easton), 2009-09, Vol.48 (37), p.8806-8816

2009

Volltextzugriff (PDF)

Management of genitourinary symptoms in patients with breast cancer: an updated systematic review of available evidence from randomized trials

Supportive care in cancer, 2023-02, Vol.31 (2), p.131, Article 131

2023

Volltextzugriff (PDF)

Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial

Canadian Medical Association journal (CMAJ), 2022-02, Vol.194 (7), p.E242

2022

Volltextzugriff (PDF)

Abstract P3-07-25: 2 year survival analysis of triple negative breast cancer from SEER data

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P3-P3-07-25

2015

Volltextzugriff (PDF)

A phase II single-arm, open-label trial of T-DM1 (ado-trastuzumab emtansine) and neratinib for HER2-positive breast cancer with molecular residual disease (KAN-HER2 MRD)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS620-TPS620

2023

Volltextzugriff (PDF)

Survival outcomes across ethnicities in triple-negative breast cancer

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.1113-1113

2014

Volltextzugriff (PDF)

Balancing the risks versus benefits of trastuzumab: A call to action for oncologists, cardiologists, and cardio-oncologists

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.554-554

2018

Volltextzugriff (PDF)

Prospective ctDNA genotyping for treatment selection in metastatic castration-resistant prostate cancer (mCRPC): The Canadian Cancer Trials Group phase II PC-BETS umbrella study

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.218-218

2023

Volltextzugriff (PDF)

Abstract P3-12-11: Cardiac toxicity in breast cancer patients: A single centre, retrospective review

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P3-P3-12-11

2015

Volltextzugriff (PDF)

Abstract P1-09-29: A new model of care for breast cancer survivorship

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P1-P1-09-29

2015

Volltextzugriff (PDF)

Prostate cancer biomarker enrichment and treatment selection (PC-BETS) study: A Canadian cancer trials group phase II umbrella trial for metastatic castration-resistant prostate cancer (mCRPC)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.5551-5551

2020

Volltextzugriff (PDF)

Validation of heart failure prediction tool in cardio-oncology breast cancer population

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e17693-e17693

2015

Volltextzugriff (PDF)

Cardiotoxicity in breast cancer patients: A single center, retrospective review

Progress in pediatric cardiology, 2015-11, Vol.39 (2), p.67-69

2015

Volltextzugriff (PDF)

Abstract P3-07-18: CCTG IND.239: A phase 2 study of combined CFI-400945 and durvalumab in patients with advanced triple negative breast cancer (aTNBC)

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P3-P3-07-18

2023

Volltextzugriff (PDF)

Abstract P3-07-10: CCTG IND.236: A Phase 1b trial of combined CFI-402257 and weekly paclitaxel in patients with HER2-negative (HER2-) advanced breast cancer (aBC)

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P3-P3-07-10

2023

Volltextzugriff (PDF)

Abstract P3-07-14: A phase II study of CFI-400945 in patients with advanced/metastatic cancer: Canadian Cancer Trials Group (CCTG) IND.237

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P3-P3-07-14

2023

Volltextzugriff (PDF)

Abstract P5-14-11: Cardiac monitoring in advanced breast cancer patients treated with trastuzumab: Does it improve cardiac safety?

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P5-P5-14-11

2020

Volltextzugriff (PDF)

136 - Pre-Printed Protocol for the Management of Diabetic Ketoacidosis

Canadian journal of diabetes, 2016-10, Vol.40 (5), p.S50-S50

2016

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(32)
Buchkapitel
(2)

Sprache

Englisch
(34)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Impact of Stopping Trastuzumab in Early Breast Cancer: A Population-Based Study in Ontario, Canada

Results of the phase I CCTG IND.231 trial of CX-5461 in patients with advanced solid tumors enriched for DNA-repair deficiencies

Young Women with Breast Cancer: The Current Role of Precision Oncology

Reproductive Outcomes in Young Breast Cancer Survivors Treated (15-39) in Ontario, Canada

Capturing the True Cost of Breast Cancer Treatment: Molecular Subtype and Stage-Specific per-Case Activity-Based Costing

Cardiac Monitoring and Heart Failure in Advanced Breast Cancer Patients Treated With Trastuzumab in Ontario, Canada

Pursuing Connectivity in Cardio-Oncology Care—The Future of Telemedicine and Artificial Intelligence in Providing Equity and Access to Rural Communities

Arsenic Metalation of Seaweed Fucus vesiculosus Metallothionein: The Importance of the Interdomain Linker in Metallothionein

Management of genitourinary symptoms in patients with breast cancer: an updated systematic review of available evidence from randomized trials

Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial

Abstract P3-07-25: 2 year survival analysis of triple negative breast cancer from SEER data

A phase II single-arm, open-label trial of T-DM1 (ado-trastuzumab emtansine) and neratinib for HER2-positive breast cancer with molecular residual disease (KAN-HER2 MRD)

Survival outcomes across ethnicities in triple-negative breast cancer

Balancing the risks versus benefits of trastuzumab: A call to action for oncologists, cardiologists, and cardio-oncologists

Prospective ctDNA genotyping for treatment selection in metastatic castration-resistant prostate cancer (mCRPC): The Canadian Cancer Trials Group phase II PC-BETS umbrella study

Abstract P3-12-11: Cardiac toxicity in breast cancer patients: A single centre, retrospective review

Abstract P1-09-29: A new model of care for breast cancer survivorship

Prostate cancer biomarker enrichment and treatment selection (PC-BETS) study: A Canadian cancer trials group phase II umbrella trial for metastatic castration-resistant prostate cancer (mCRPC)

Validation of heart failure prediction tool in cardio-oncology breast cancer population

Cardiotoxicity in breast cancer patients: A single center, retrospective review

Abstract P3-07-18: CCTG IND.239: A phase 2 study of combined CFI-400945 and durvalumab in patients with advanced triple negative breast cancer (aTNBC)

Abstract P3-07-10: CCTG IND.236: A Phase 1b trial of combined CFI-402257 and weekly paclitaxel in patients with HER2-negative (HER2-) advanced breast cancer (aBC)

Abstract P3-07-14: A phase II study of CFI-400945 in patients with advanced/metastatic cancer: Canadian Cancer Trials Group (CCTG) IND.237

Abstract P5-14-11: Cardiac monitoring in advanced breast cancer patients treated with trastuzumab: Does it improve cardiac safety?

136 - Pre-Printed Protocol for the Management of Diabetic Ketoacidosis

Suchergebnisse filtern